Role of platelet inhibitor therapy in myocardial infarction Bernardo SteinValentin Fuster Review Pages: 797 - 813
Ace inhibitors compared with thiazide diuretics as first-step antihypertensive therapy I. J. PerryD. G. Beevers Hypertension Pages: 815 - 819
Life's quality: A major consideration in health care delivery — Especially with hypertensive diseases Edward D. Frohlich Hypertension Pages: 821 - 823
The cost of new drugs in the treatment of hypertension — The Australian experience W. J. Louis Hypertension Pages: 825 - 827
Naloxone does not antagonize the antihypertensive effect of chronic captopril therapy in hypertensive patients G. P. BerniniA. R. LucariniA. Salvetti Hypertension Pages: 829 - 833
Effects of long-term nicardipine treatment on hemodynamics of large arteries in essential hypertension E. ArosioP. PanceraA. Lechi Hypertension Pages: 835 - 839
Treatment of hypertension based on both systolic and diastolic pressure could influence the cost of therapy Michel Safar Hypertension Pages: 841 - 845
Angiotension-converting enzyme inhibition and the cardiovascular system Luc Rochette Angiotensin Converting Enzyme Inhibition and the Cardiovascular System Pages: 853 - 853
Editorial comment ACE inhibitors and cardioprotection Alberto Zanchetti Angiotensin Converting Enzyme Inhibition and the Cardiovascular System Pages: 855 - 857
Carotid arterial hemodynamics in hypertension: Acute administration of captopril or cadralazine P. J. LacolleyS. T. LaurentM. E. Safar Angiotensin Converting Enzyme Inhibition and the Cardiovascular System Pages: 859 - 863
Differential systemic and regional hemodynamic profiles of four angiotensin-I converting-enzyme inhibitors in the rat Christine RicherMarie-Pascale DoussauJean-François Giudicelli Angiotensin Converting Enzyme Inhibition and the Cardiovascular System Pages: 865 - 872
Cardiac arrhythmias are ameliorated by local inhibition of angiotensin formation and bradykinin degradation with the converting-enzyme inhibitor ramipril Wolfgang LinzBernward A. SchölkensPatricia Petry Angiotensin Converting Enzyme Inhibition and the Cardiovascular System Pages: 873 - 882
The use of angiotensin-converting enzyme inhibitors in congestive heart failure Jean L. RouleauCarl JuneauJacques de Champlain Angiotensin Converting Enzyme Inhibition and the Cardiovascular System Pages: 883 - 890
Abstracts of Papers Presented at a Symposium on The Physiopathology of Reperfusion L. Rochette Abstract Pages: 891 - 891
Ibopamine versus hydrochlorothiazide/amiloride in patients with mild congestive heart failure SK & F Ibopamine Working GroupElisabetta RivaR. Friederici Congestive Heart Failure Pages: 897 - 902
Felodipine in severe chronic congestive heart failure: Acute effects on central hemodynamics and regional blood flow distribution Giorgio BinettiIda RubinoBruno Magnani Congestive Heart Failure Pages: 903 - 911
Acute and long-term hemodynamic response to low-dose enoximone in refractory heart failure Kenneth M. McDonaldJohn J. O'SullivanBrian J. Maurer Congestive Heart Failure Pages: 913 - 918
Documentation of an instrument for assessment of subjective CNS-related symptoms during cardiovascular pharmacotherapy C. DahlöfE. DimenäsB. Olofsson New Methods Pages: 919 - 927
The relation of quinidine-Induced elevation of serum digoxin concentration to the conversion of atrial fibrillation-flutter: A pilot study Sumatilal ShahHoward S. Friedman Rapid Communication Pages: 929 - 930
The costs of treatment of hypertension in Switzerland and Worldwide Wilhelm J. Rutishauser Rapid Communication Pages: 931 - 933
